![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
8 weeks sofosbuvir/velpatasvir in genotype 3 patients with significant fibrosis:
Highly effective amongst an OST cohort
|
|
|
Reported by Jules Levin
EASL April 13 Paris France
Alison Boyle1, F Marra1, E Peters1 , M Heydtmann2 , H Cairns1,
S Datta3 , ST Barclay4
1Gartnavel General Hospital, Glasgow, Scotland, 2Royal Alexandra Hospital,
Paisley, Scotland, 3Queen Elizabeth University Hospital, Glasgow, Scotland,
4Glasgow Royal Infirmary, Glasgow, Scotland
![0413181](../images%20/041318/041318-12/0413181.gif)
![0413182](../images%20/041318/041318-12/0413182.gif)
![0413183](../images%20/041318/041318-12/0413183.gif)
![0413184](../images%20/041318/041318-12/0413184.gif)
![0413185](../images%20/041318/041318-12/0413185.gif)
![0413186](../images%20/041318/041318-12/0413186.gif)
![0413187](../images%20/041318/041318-12/0413187.gif)
![0413188](../images%20/041318/041318-12/0413188.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|